Conduit Pharmaceuticals Inc. (CDT)
USD 0.07
(-10.01%)
USD 0.07
(-10.01%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -7.72 Million | -2.26 Million | -2.15 Million |
| Net Income | -535 Thousand | -4.88 Million | -3.65 Million |
| Depreciation & Amortization | - | - | - |
| Deferred income taxes | - | - | - |
| Stock-based compensation | 199 Thousand | - | - |
| Change in working capital | -2.51 Million | 927 Thousand | 1.35 Million |
| Other non-cash items | -4.87 Million | 1.69 Million | 149 Thousand |
| Investing Cash Flow | 725 Thousand | -183 Thousand | 48.55 Thousand |
| Investments in PPE | - | - | - |
| Acquisitions | - | - | - |
| Investment purchases | - | -134.89 Million | - |
| Sales/Maturities of investments | 497 Thousand | 148 Thousand | - |
| Other Investing Activities | 228 Thousand | 134.56 Million | - |
| Financing Cash Flow | 10.92 Million | 2.44 Million | 1.89 Million |
| Debt repayment | -2.28 Million | -177.05 Thousand | -75 Thousand |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | - | 1.34 Million | 1.21 Million |
| Other Financing Activities | 8.64 Million | 1.28 Million | 763 Thousand |
| Accounts receivables | - | - | - |
| Accounts payables | 215 Thousand | - | - |
| Inventory | - | - | - |
| Other working capital | -2.73 Million | 927 Thousand | 1.35 Million |
| Cash at beginning of period | - | 48.55 Thousand | 252 Thousand |
| Cash at end of period | 4.22 Million | 345.77 Thousand | 48.55 Thousand |
| Capital Expenditure | - | - | - |
| Effect of forex changes on cash | 299 Thousand | 1000.00 | 1000.00 |
| Net cash flow / Change in cash | 4.22 Million | 297.22 Thousand | -203.44 Thousand |
| Free Cash Flow | -7.72 Million | -2.26 Million | -2.15 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 53.67 Million | -5.38 Million | -3.57 Million | -535 Thousand | 1.77 Million | 1.98 Million |
| Depreciation & Amortization | 31.04 Million | 23.51 Million | 26.98 Million | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 7.43 Million | 483 Thousand | 431 Thousand | 199 Thousand | 189 Thousand | 10 Thousand |
| Change in working capital | 68.27 Million | 610 Thousand | -201 Thousand | -2.51 Million | -4.21 Million | 1.76 Million |
| Other non-cash items | -68.76 Million | 2.35 Million | 1.51 Million | -4.87 Million | -2.55 Million | -5.52 Million |
| Investing Cash Flow | -320.58 Million | -224 Thousand | -24.19 Million | 725 Thousand | 497 Thousand | -114.24 Million |
| Investments in PPE | -24.51 Million | -10 Thousand | -24.25 Million | - | - | - |
| Acquisitions | -296.17 Million | - | - | - | - | - |
| Investment purchases | 490 Thousand | -490 Thousand | - | - | - | 389.94 Thousand |
| Sales/Maturities of investments | -276 Thousand | 276 Thousand | - | 497 Thousand | - | -114.86 Million |
| Other Investing Activities | 106 Thousand | -224 Thousand | 60 Thousand | 228 Thousand | 497 Thousand | 227.99 Thousand |
| Financing Cash Flow | -17.41 Million | 113 Thousand | -64.93 Million | 10.92 Million | -414 Thousand | 124.74 Million |
| Debt repayment | -239 Thousand | - | -227 Thousand | -2.28 Million | -5000.00 | -1.53 Million |
| Dividends payments | -2.03 Million | - | -2.07 Million | - | - | - |
| Common Stock Repurchased | 58.05 Million | - | - | - | - | 114.06 Million |
| Common Stock Issuance | 5.76 Million | 113 Thousand | 3.15 Million | - | -498 Thousand | 498 Thousand |
| Other Financing Activities | -78.96 Million | 113 Thousand | -65.78 Million | 8.64 Million | 8.49 Million | 8.64 Million |
| Accounts receivables | -27.63 Million | - | 54.47 Million | - | - | - |
| Accounts payables | 36.36 Million | 908 Thousand | -97 Thousand | 215 Thousand | 209 Thousand | 6000.00 |
| Inventory | 8.71 Million | - | -9.65 Million | - | - | - |
| Other working capital | -36.02 Million | -298 Thousand | -104 Thousand | -2.73 Million | -4.42 Million | 1.49 Million |
| Cash at beginning of period | 564.75 Million | 1.84 Million | 4.22 Million | - | 8.64 Million | 277.76 Thousand |
| Cash at end of period | 322.98 Million | 219 Thousand | 1.84 Million | 4.22 Million | 4.22 Million | 8.64 Million |
| Capital Expenditure | -24.51 Million | -10 Thousand | -24.25 Million | - | - | - |
| Effect of forex changes on cash | 4.55 Million | -1000.00 | -27 Thousand | 299 Thousand | 304 Thousand | -11 Thousand |
| Net cash flow / Change in cash | -241.76 Million | -1.62 Million | -2.38 Million | 4.22 Million | -4.41 Million | 8.36 Million |
| Free Cash Flow | 67.16 Million | -1.52 Million | -26.6 Million | -7.72 Million | -4.8 Million | -1.78 Million |
0JUJ
LBTYB
SMTK
SPZ
8158
DSX